Seminal studies by Kane et al. were among the first to demonstrate that Aβ pathology could be induced in young APP transgenic host mice by injection of small amounts of brain homogenates prepared from human AD brains or from older APP mice with high amyloid burden [17]. The gene discussed is APP; the disease is Alzheimer disease.